PBC Living®

PBC Living® helps you to take an active role in tracking and monitoring all aspects
of your primary biliary cholangitis (PBC).

Now you can log your symptoms daily, view your symptom history over time, and save
questions you would like to ask your doc tor or nurse. PBC Living provides a single place
to store and share all the information that is important for you and your PBC.

Features:
- Symptom trackers for itching, mood, sleep, and energy level
- Liver marker trackers to input your alkaline phosphatase (ALP) and bilirubin levels
from lab reports
- Charts to view your symptom history and liver marker levels over time
- Notes section to store questions to share with your healthcare team
- Educational information through LivingwithPBC.com, your go-to online resource
for PBC

What’s New:

Version 2.3.3
- Fixes and improvements
- Option to delete account and associated personal data
- Addition of new trackable biomarkers: alanine aminotransferase (ALT), aspartate
aminotransferase (AST), and gamma-glutamyl transferase (GGT)

Version 2.3.2
Fixes and improvements

Version 2.3.1
Minor bug fixes and API Updates

Version 2.3.0
More robust support for 1OS 15
Minor bug fixes and UI improvements

Version 2.2.2
We've updated the app for a better experience across iOS 12, 13, and 14, and fixed an
issue with the "forgot password" flow that was affecting a subset of users

Version 2.1
Bug fixes and improvements

Version 2.0.1
Fixes start up crash for users that updated from v 1.0

As of version 2.0, we've included the following new features:
• Ability to retroactively track symptoms and lab levels
• Calendar functionality to track and add important reminders, such as medications, refills,
and appointments
• Notes sections in key areas for context while tracking
• Design enhancements and improved navigation
• Settings page for important links and user controls

Information Seller: Intercept Pharmaceuticals, Inc .
Category : Medical
Version: 2.3.3
Compatibility : Requires iOS 8 and higher.
Language: English
© 2025 Intercept Pharmaceuticals, Inc.